Goh SH - Search Results

1

FOXM1 Inhibition Enhances the Therapeutic Outcome of Lung Cancer Immunotherapy by Modulating PD-L1 Expression and Cell Proliferation.

Madhi H, Lee JS, Choi YE, Li Y, Kim MH, Choi Y, Goh SH. Madhi H, et al. Among authors: goh sh. Adv Sci (Weinh). 2022 Oct;9(29):e2202702. doi: 10.1002/advs.202202702. Epub 2022 Aug 17. Adv Sci (Weinh). 2022. PMID: 35975458 Free PMC article.

2

Hyaluronic acid-polypyrrole nanoparticles as pH-responsive theranostics.

Park D, Cho Y, Goh SH, Choi Y. Park D, et al. Among authors: goh sh. Chem Commun (Camb). 2014 Dec 11;50(95):15014-7. doi: 10.1039/c4cc06349j. Chem Commun (Camb). 2014. PMID: 25327482

3

Photosensitizer-conjugated tryptophan-containing peptide ligands as new dual-targeted theranostics for cancers.

Kim J, Chae J, Kim JS, Goh SH, Choi Y. Kim J, et al. Among authors: goh sh. Int J Pharm. 2016 Nov 20;513(1-2):584-590. doi: 10.1016/j.ijpharm.2016.09.071. Epub 2016 Sep 26. Int J Pharm. 2016. PMID: 27686051

4

CD44v8-10 as a potential theranostic biomarker for targeting disseminated cancer cells in advanced gastric cancer.

Choi ES, Kim H, Kim HP, Choi Y, Goh SH. Choi ES, et al. Among authors: goh sh. Sci Rep. 2017 Jul 10;7(1):4930. doi: 10.1038/s41598-017-05247-7. Sci Rep. 2017. PMID: 28694503 Free PMC article.

5

Redox-Responsive Manganese Dioxide Nanoparticles for Enhanced MR Imaging and Radiotherapy of Lung Cancer.

Cho MH, Choi ES, Kim S, Goh SH, Choi Y. Cho MH, et al. Among authors: goh sh. Front Chem. 2017 Dec 4;5:109. doi: 10.3389/fchem.2017.00109. eCollection 2017. Front Chem. 2017. PMID: 29255705 Free PMC article.

6

Porous platinum nanoparticles as a high-Z and oxygen generating nanozyme for enhanced radiotherapy in vivo.

Li Y, Yun KH, Lee H, Goh SH, Suh YG, Choi Y. Li Y, et al. Among authors: goh sh. Biomaterials. 2019 Mar;197:12-19. doi: 10.1016/j.biomaterials.2019.01.004. Epub 2019 Jan 4. Biomaterials. 2019. PMID: 30623793

7

A redox-responsive theranostic agent for target-specific fluorescence imaging and photodynamic therapy of EGFR-overexpressing triple-negative breast cancers.

Kim J , Won Y , Goh SH , Choi Y . Kim J , et al. Among authors: goh sh. J Mater Chem B. 2016 Nov 14;4(42):6787-6790. doi: 10.1039/c6tb01519k. Epub 2016 Sep 27. J Mater Chem B. 2016. PMID: 32263572

8

Quenched cetuximab conjugate for fast fluorescence imaging of EGFR-positive lung cancers.

Kim H , Goh SH , Choi Y . Kim H , et al. Among authors: goh sh. Biomater Sci. 2021 Jan 21;9(2):456-462. doi: 10.1039/d0bm01148g. Epub 2020 Aug 6. Biomater Sci. 2021. PMID: 32760993

9

FAM188B Expression Is Critical for Cell Growth via FOXM1 Regulation in Lung Cancer.

Choi YE, Madhi H, Kim H, Lee JS, Kim MH, Kim YN, Goh SH. Choi YE, et al. Among authors: goh sh. Biomedicines. 2020 Oct 31;8(11):465. doi: 10.3390/biomedicines8110465. Biomedicines. 2020. PMID: 33142744 Free PMC article.

10

ELF3 Is a Target That Promotes Therapeutic Efficiency in EGFR Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer Cells via Inhibiting PKCί.

Lee JS, Choi YE, Kim S, Han JY, Goh SH. Lee JS, et al. Among authors: goh sh. Int J Mol Sci. 2021 Nov 13;22(22):12287. doi: 10.3390/ijms222212287. Int J Mol Sci. 2021. PMID: 34830169 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

222 results

Search Page

Filters